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Abstract
Background: Despite proven efficacy of the prevention mother-to-child transmission of HIV strategy, its adoption
in Africa has remained slow. In Kenya, its effectiveness remain unknown. The aim of this study was to assess the
effectiveness of a prevention of mother-to-child transmission program in Kenya.
Methods: This retrospective cross-sectional study analyzed 2,642 records of HIV-exposed infants who had a
deoxyribonucleic acid polymerase chain reaction test done. The main outcome measure was HIV vertical
transmission rates, stratified by i) infant age at diagnosis, ii) maternal prophylaxis and iii) infant mode of feeding.
The characteristics of the infants who tested positive were compared to those who tested negative using Chi-
square and Wilcoxon-Ranksum test. Bivariate and multivariate logistic regression analyses were conducted to
establish associations and explore relationship between covariates and HIV transmission.
Results: One thousand and one hundred nineteen (42.4%) infants had dried blood spot samples taken for HIV
deoxyribonucleic acid polymerase chain reaction test within the first 6 weeks of age. Median age at diagnosis for
HIV-positive infants was 4 months (IQR 1.5–9) while that of HIV-negative infants was 2 months (IQR 1.5–6). In total,
1,906 (72.1%) infants received prophylactic antiretrovirals. Infants whose mothers received prophylaxis had
significantly lower vertical transmission rate (6.7%) compared to those whose mothers did not receive prophylaxis
(24.0%), (OR 0.23, p < 0.001). When adjusted for feeding option and infant’s age at diagnosis, the odds of
transmission among women who received prophylaxis was 76% lower than that of women who did not receive
any prophylaxis (OR 0.2 p < 0.001). 1,368 infants less than 6 months of age, 67.3%) were exclusively breastfed, 214
(10.5%) were replacement fed, and 164 (8.1%) mixed fed. Mixed feeding was associated with increased risk of HIV
transmission (OR 2.7, p = 0.007). 67% of children older than 6 months were breastfed and had higher HIV
transmission rate compared to those who were not breastfed (OR 2.3, p = 0.006).
Conclusions: The recorded rate of 9.3%, suggest the interventions implemented at the study sites were moderately
effective, more so when provided early. Program performance will improve should the 12.8% of pregnant women
who did not receive antiretroviral prophylaxis are reached.
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Background
In 2011, the United Nations General Assembly commit-
ted to the Global Plan that sought to eliminate new HIV
infections among children by 2015 and keep their
mothers alive [1]. Subsequently, the World Health
Organization (WHO) issued the consolidated guidelines
in 2013, recommending lifelong use of antiretroviral
therapy (ART) for all pregnant women regardless of
their CD4 count [2, 3]. This intervention is also referred
to as prevention of mother-to-child transmission
(PMTCT) option B+. However, despite its proven
efficacy and cost effectiveness, the adoption of PMTCT
Option B+ remains slow [3–5].
Numerous contextual and health systems factors ham-
per the adoption of best practices in resource limited
settings. In Sub-Saharan Africa where 90% of mother-to-
child transmission (MTCT) of HIV occurs, achieving
90% reduction of MTCT (from 2009 estimates) and
reaching a transmission rate of 5% by 2015 remains a
challenge [6]. It has been established that women and in-
fants who do not access PMTCT intervention have 15–
30% risk of MTCT in pregnancy and delivery, which in-
creases to 20–45% during breastfeeding [7]. Early Infant
Diagnosis (EID) remains a key test in measuring the ex-
tent to which PMTCT interventions have averted
MTCT. It is also the entry point for HIV-exposed infants
(HEI) to early clinical evaluation, prophylaxis for oppor-
tunistic infections and ART [3]. In resource limited set-
tings, without any therapeutic intervention, up to 35 and
52% of HIV infected infants die by age one year and two
years respectively [7, 8].
Although several studies have been done in Sub-
Saharan Africa on the effectiveness of PMTCT programs
and factors associated with HIV sero-positivity among
HIV exposed infants [9–11], little is known of the effect-
iveness of the PMTCT programs in the Kenyan public
health sector context. The successful roll out of proven
effective public health interventions such as PMTC is
highly dependent on the ability of country health sys-
tems to embed the interventions in routine service deliv-
ery and people in need must be able to utilize the
services. The purpose of our study was to assess the ef-
fectiveness of a PMTCT program implemented in the
South Rift region of Kenya. The measurement of vertical
transmission rates of HIV in a program serves as proxy
of the degree of availability and uptake of PMTCT ser-
vices. This information is critical to inform public health
policy, planning and resource allocation.
Methods
Study design
This was a cross-sectional survey of the EID results of
infants enrolled in the USAID-funded APHIA Plus pro-
ject in the South Rift region of Kenya between January
1st and December 31st 2013. The survey included the
EID records of all HIV exposed infants enrolled in the
AIDS, Population and Health Integrated Assistance
(APHIA) Plus Rift project-supported health facilities.
Setting and sample
The sites included in this study were public health facil-
ities that cater mostly for uninsured patients, majority of
whom were of low socio economic status. The South
Rift region is predominantly rural and consists of five
counties namely; Baringo, Kajiado, Laikipia, Nakuru and
Narok, with a total population of 4,888,222 in 2013.
Agriculture is the mainstay of the economy. The APHIA
Plus project supported health facilities in all the five
counties. The majority (70%) were primary care facilities
[12]. The support to PMTCT sites consisted of skills
building through mentorship, orientation to new guide-
lines, standard operating procedures and job aids;
sensitization to best practices and on the job training;
laboratory networking for CD4, PCR and viral load sam-
ples referral; support to mentor mothers and sessional
counsellors.
In total, 2772 dry blood spot (DBS) were tested during
the observation period. Using both sample code and
facility name, 94 duplicate entries were identified and re-
moved. Further data cleaning excluded 35 records whose
HIV status was missing and one record whose value for
infant age was above 18 months at the time of diagnosis.
After data cleaning our final data set consisted of 2642
records. The majority of records were from Nakuru
(1591, 60.2%), followed by Kajiado (499, 18.9%), Narok
(222, 8.4%), Laikipia (189, 7.2%), and Baringo 141 (5.3%).
Procedure
Typically, HIV counselling and testing on an opt-out ap-
proach was provided through a trained health care
worker to expectant mothers on their first visit as part
of the antenatal care package. Nationally approved test-
ing algorithms were used (Determine® as the first test,
Bio-line® as the second test, and Unigold® as the tie-
breaker). For consenting mothers, results were provided
the same day [13]. Women who tested negative for HIV
were further counselled on prevention. Women who
tested positive were started on antiretroviral prophylaxis
as per the prevailing Kenyan guidelines that gave clini-
cians four options: i) single dose Nevirapine at onset of
labor; ii) maternal AZT from 14 weeks gestation with
addition of 3TC and Nevirapine at onset of labor, and
infant AZT and 3TC for a week; iii) ART during preg-
nancy and cessation after breastfeeding (interrupted
ART) and iv) lifelong ART initiated at first contact with
the mother during pregnancy (Option B+) [14]. HIV
positive pregnant women were enrolled in care, and
given a comprehensive package as stipulated in the
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national PMTCT guidelines. Upon birth the infants were
also enrolled in a follow up program in the maternal,
newborn and child health unit [14].
EID in APHIAPlus Rift supported facilities followed
the national algorithm. To establish HIV exposure
status, all infants of unknown status aged ≤18 months
received an HIV antibody test at their first clinical visit.
Infants who turned positive on HIV antibody test were
referred for a DNA PCR test. Using the heel stick
method, DNA PCR samples were obtained as DBS on
Whatman filter paper and shipped to one of the six ref-
erence laboratories as determined by both proximity and
ease of transport logistics. The six reference laboratories
were: i) Kenya Medical Research Institute CVR HIV-P3
in Nairobi County; ii) Kenya Medical Research Institute
CDC HIV/R in Kisumu; iii) Kenya Medical Research In-
stitute CIPDCR Alupe in Busia County; iv) Kenya Med-
ical Research Institute/Walter Reed CRC in Kericho
County; v) AMPATH reference laboratory Eldoret in
Uasin Gishu County; and vi) Coast provincial general
hospital molecular laboratory in Mombasa county.
DNA PCR positive infants were started on co-
trimoxazole and ART from the age of 6 weeks. DNA
PCR negative infants were retested at 9 months. A con-
firmatory DNA PCR test was offered to HIV antibody
positive infants. DNA PCR negative infants received an
HIV antibody repeat test at 18 months and if older, a
week after cessation of breastfeeding.
DBS samples collected from HIV exposed infants in
APHIA Plus-Rift supported facilities were transported to
one of six national reference laboratories. Once proc-
essed and analyzed, results were transmitted back to the
referring health facility in both hard and digital copy in
sites with an existing SMS printer. In addition, the na-
tional reference laboratory retained records of all test
done and reported into the national EID database ac-
cessible through the National AIDS and STI Control
Program website [15]. The website has inbuilt validation
checks that serve to minimize errors during data entry.
We accessed these routine service data for the APHIA
Plus -Rift supported sites from the NASCOP’s EID web-
site, downloaded as an excel spreadsheet.
Variables
The standard EID data collection tool has fields for ma-
ternal and infant data. Key variables considered included:
demographic data; type of maternal antiretroviral
prophylaxis regimen received; infant feeding options
adopted; and facility-entry point/department at diagnosis
and infants’ age at testing. Infant feeding options were
classified as exclusive breastfeeding, mixed, and replace-
ment feeding for infants under-six months; and breast-
feeding and no breastfeeding for those above six months
at the time of testing.
Facilities were categorized according to the Kenya
Health Policy into tier one (community level), tier two
(primary level), tier three (secondary or county level
referral hospital) and tier four (tertiary level referral
facilities) [12].
Statistical analysis
Data was exported into STATA/SE 12.1 (STATA Corpor-
ation LP 4905 Lakeway Drive) for analysis. Our primary
outcome of interest was the DBS test result as an indica-
tor of PMTCT interventions success or lack thereof. We
compared the characteristics of HIV exposed infants
who tested positive to those who tested negative. We
used the Chi-square test for categorical variables and
Wilcoxon-Ranksum test and median tests for age vari-
able which followed a non-normal distribution. In re-
cords where the feeding option was considered invalid
based on the national EID reporting tool, the value was
set to missing. We conducted bivariate logistic regres-
sion analysis to examine associations between the
dependent variable (infant HIV status) and independent
variables such as maternal antiretroviral regimen, infant’s
age at DBS test, infants’ sex, the method of feeding and
the health facility category (tier). We included variables
that had a p value of ≤ 0.25 in the bivariate analyses.
We then conducted multivariable logistic regression to
explore relationship between various covariates and
vertical HIV transmission. We also explored effects of
confounders and interactions of various covariates on
vertical transmission.
Results
Description of infants in the study
Infant age in the dataset ranged from birth to 18 months
distributed as follows: 42% aged 6 weeks and below, 48%
aged between 6 weeks and 9 months, 9% were above
9 months and only 1% were missing age variable. The
majority (77.4%) were aged less than 6 months. A hun-
dred and twelve records (4.2%) had no sex recorded.
(Table 1).
Overall 245 infants tested positive. This represents a
9.3% positivity rate. Only 1,119 (42.4%) of the infants
were tested within the first 6 weeks of age as per the
national guidelines while 1,261 (47.7%) were tested
between 6 weeks and 9 months. Two hundred and forty-
four (9.2%) infants were tested after 9 months. Overall,
the median age at the time of DBS sample collection
was 2 months (Interquartile range (IQR); 1.5 –
6 months). HIV positive infants however were signifi-
cantly older at the time of first DBS sample collection
(OR 1.1[1.07–1.13] p < 0.001) compared to those who
tested negative. The median age at diagnosis for the
positive infants was 4 months (IQR 1.5 – 9 months),
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double the median age for the negative children
(2 months; IQR 1.5 – 6 months).
Uptake of maternal antiretroviral prophylaxis and infant
feeding practices
Table 2 shows that almost three quarters of infants’
mothers 1,906 (72.1%) received ARV for PMTCT. Out
of these, 810 (42.5%) received the more efficacious life-
long ART regime and 133 (7.0%) were on interrupted
ART. The rest received either Zidovudine from 14 weeks
(32.3%), single dose Nevirapine (2.7%) or other unspeci-
fied regimens (15.5%). About two thirds of infants <
6 months of age (1368, 67.3%) were exclusively breast-
fed, 214 (10.5%) were on replacement feeding and 164
(8.1%) were on mixed feeding. Data on feeding option
were missing in 286 (14.1%) entries. More than half the
infants aged >6 months (357, 60.3%) were still breast
feeding. A total of 245 (9.3%) HIV exposed infants tested
positive with no significant difference between male
(10.1%) and female (8.4%) (OR 1.22, p = 0.152).
Although there was no significant variation in trans-
mission rates between facility tiers (primary care, county
or national referral) we observed this variation between
counties. Narok County had a significantly higher posi-
tivity compared to Baringo county which had the lowest
positivity (OR 2.99, p = 0.012). (Table 3).
Determinants of infant's HIV
From bivariate analyses, infants whose mothers received
antiretroviral prophylaxis had a significantly lower HIV
vertical transmission rate (6.7%) compared to infants
whose mothers did not receive prophylaxis (24.0%) (OR
0.23; p < 0.001). The type of antiretroviral regimen taken
by the mother was significantly associated with a nega-
tive DBS test result (p <0.001). Mixed feeding was asso-
ciated with close to threefold increase in the risk of
vertical transmission among infants aged less than six
months (OR 2.75; p =0.007). Continued breastfeeding
alongside complementary feeds beyond six months was
associated with increased transmission rates (OR 2.27; p
=0.006). See Table 2 above.
In our adjusted model, we found that all antiretroviral
regimens used perinatally reduced the rates of vertical
HIV transmission. ART for instance, reduced vertical
HIV transmission rates by 70% (aOR 0.3 p < 0.001)
while AZT combined with single dose nevirapine and
3TC reduced transmission by 59% (aOR 0.41, p <0.001).
There was no statistically significant difference in trans-
mission rates between children whose mothers were on
ART and those on AZT + single-dose nevirapine + 3TC
(aOR 0.74 p = 0.211). Compared to infants enrolled
through MCH, the odds of a positive DNA PCR result
for infants enrolled through other entry points was 1.44
(p < 0.001). Children who were enrolled through the in-
patient wards were significantly more likely to be HIV-
infected compared to those enrolled through the MCH
(aOR 5.13, p < 0.001). There was no significant differ-
ence in transmission rates between the five counties in
the adjusted model.
Table 1 Baseline Characteristics of infants in the study (N = 2642)





n (%) n (%)
Sex
Male 1271 128 (10.1) 1143 (89.9)
Female 1259 106 (8.4) 1153 (91.6)
Missing 112 11 (9.8) 101 (91.2)
Age at testing
≤ 6 weeks 1119 71 (6.3) 1048 (93.7)
> 6 weeks to
9 months
1261 115 (9.1) 1146 (90.9)
> 9 months 244 58 (23.8) 186 (76.2)
Missing 18 1 (5.6) 17 (94.4)
Table 2 Maternal antiretroviral prophylaxis and infant feeding









Received prophylaxis 1906 (72.1) 127 (6.7) 1779 (93.3)
No prophylaxis 338 (12.8) 81 (24.0) 257 (76.0)
Missing 398 (15.1) 37 (9.3) 361 (90.7)
Type of maternal
antiretroviral regimen
n = 1906, (%)
Lifelong ART 810 (42.5) 48 (5.9) 762 (94.1)
AZT + (3TC + sd-NVP
at labour) + (AZT + 3TC
for 7 days)
616 (32.3) 41 (6.7) 575 (93.3)
Interrupted ART 133 (7.0) 6 (4.5) 127 (95.5)
Sd-NVP only 51 (2.7) 1 (2.0) 50 (98.0)
Others 296 (15.5) 31 (10.5) 265 (89.5)
Infant feeding option
< 6 months n = 2032, (%)
Exclusive replacement
feeding (ERF)
214 (10.5) 12 (5.6) 202 (94.4)
Exclusive breastfeeding
(EBF)
1368 (67.3) 97 (7.1) 1271 (92.9)
Mixed feeding (MF) 164 (8.1) 23 (14.0) 141 (86.0)
Missing 286 (14.1) 22 (7.7) 264 (92.3)
> 6 months n = 592, (%)
Not breastfeeding (NBF) 179 (30.2) 16 (8.9) 163 (91.1)
Breastfeeding (BF) 357 (60.3) 65 (18.2) 292 (81.8)
Missing 56 (9.5) 9(16.1) 47 (83.9)
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Although age at DNA PCR test and the mode of infant
feeding were found to be significant in our bivariate ana-
lyses, in multivariable model these two variables ceased
to be significant. The infant’s sex was not significantly
associated with the outcome in both bivariate and multi-
variable analyses (see Table 4)
Discussion
The PMTCT program in the APHIAPlus Rift project
may have been effective as evidenced by the results of
lower transmission rates (9.27% overall positivity) among
the population attending PMTCT programs, compared
to15-45% transmission rates expected from literature
with no PMTCT intervention. This however falls short
of the target of reducing MTCT rates to less than 5%.
Although 72% of mothers in the study population
receiving any form of antiretroviral prophylaxis, access
to the more efficacious regimes including the option B+
remains low (53%) and only 42% of HEI test at ≤6 weeks
of age. Yet our study findings suggest early infant age at
PCR testing, exclusive breastfeeding and lifelong use of
maternal ART for prophylaxis are associated with low-
ered vertical transmission of HIV.
Timing of early infant diagnosis
The 2013 WHO guidelines call for the first DNA PCR
for early infant diagnosis at between 0 and 6 weeks [3].
This mirrors the Kenyan guidelines which make a simi-
lar recommendation of conducting the first DNA PCR
at 0–6 weeks, In our study 1119 (42.4%) of infants
received their first DNA PCR at between 0 and 6 weeks.
In earlier multi-country analyses of Nigeria, Uganda and
Namibia, the proportion of first DNA PCR tests done in
the first two months of life was less than 50% [16]. The
lowest ages were seen at tertiary centers that were
known to have robust PMTCT services [16, 17].
Although the latter examined infants up to the age of
two months, we project that if we examined a similar
group, our uptake of the first DNA PCR would be
slightly higher. We do note however that the multi-
country analyses were done in 2011; 2 years earlier than
our study hence the divergent comparison group –
under two months vis-a-vis 0–6 weeks. That notwith-
standing, our results may reflect the growing impetus
towards earlier testing, a move considered pivotal in
curbing perinatal infections [18].
Further, we found that on DNA PCR testing, infants
who tested positive were older than those who tested
negative. This is consistent with current findings in
Kenya. Hassan et al. noted that late entry at enrollment
into EID program and high dropout rate were associated
with increased rates of positivity. Majority of infants
enrolled at over two months of age, had been referred
from acute or chronic clinical services and therefore sick
at the outset [19]. Elsewhere, findings from the Kiliman-
jaro region of Tanzania are no different [20]. O’Donnell
et al. observed that reluctance to child testing may be re-
lated to various issues around acceptability. Cultural
norms dictating that young infants should not be taken
outside the house except for receipt of vaccine (not
always collocated with EID), serve to provide insights
into this observation [20].
Infant feeding options
In our study, over two thirds 1368 (67.3%) of infants
younger than six months, were breastfed exclusively;
three fifths, 357 (60.3%) of infants above 9 months were
breastfeeding when the first DNA PCR was taken. Simi-
lar high rates of exclusive breastfeeding were observed
in Nigeria and Zambia at 80 and 84% respectively [21,
22]. Findings of high exclusive breastfeeding rates in the
general population are uncommon and therefore
surprising since adherence to exclusive breastfeeding in
our setting is generally low [23]. In many societies of
sub-Saharan Africa, encouraging mothers to practice
exclusive breastfeeding is far from easy. Often, babies
Table 3 Univariate analysis of infant HIV status by health facility tier and by county
Facility Tier N = 2642 EID test outcome (HIV status) OR [95% CI] p -value
Total Negative n(%) Positive n(%)
Tier 2 1053 963 (91.4) 90 (8.6) Ref (1)
Tier 3 1125 1015 (90.2) 110 (9.8) 1.16 [0.87–1.6] 0.32*
Tier 4 464 419 (90.3) 45 (9.7) 1.15 [0.79–1.67] 0.47*
County name N = 2642
Baringo 141 134 (95.0) 7 (5.0) Ref. (Ref)
Kajiado 499 457 (91.6) 42 (8.4) 1.76 [0.77–4.0] 0.18*
Laikipia 189 157 (91.0) 17 (9.0) 1.89 [0.76–4.69] 0.17*
Nakuru 1591 1442 (90.6) 149 (9.4) 1.98 [0.91–4.31] 0.09*
Narok 222 192 (86.5) 30 (13.5) 2.99 [1.28–7.01] 0.01**
OR[95% CI] unadjusted Odds ratio with the 95% confidence interval, Ref (1) Reference category
*: Statistically insignificant (P ≥ 0.05), **: Statistically significant (P < 0.05)
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are given water, tea, porridge or other foods alongside
breast milk in the first few weeks of life [24]. A study
done in Malawi to find out about feeding practices of
children showed that 65% of infants were given other
foods within 1 month of life and only 4% of infants were
exclusively breastfed [25]. In Cameroon, Noubiap et al.
reported exclusive breastfeeding rates of 44.6%, while
Tejiokem et al. found exclusive breastfeeding rates of
10.7% [17, 26]. According to the KDHS 2008–09, exclu-
sive breastfeeding is not common as only 32% of infants
less than 6 months are exclusively breastfed [23]. Add-
itionally, infants in our study who had been categorized
as either having been breastfed exclusively or mixed fed
showed an incremental transmission rate with age.
We found a third (32.4%) of mothers received the
option B+, while slightly over a fifth (22.9%). received AZT
mono-therapy and single-dose Nevirapine at onset of
labor. In line with evidence elsewhere, the use of maternal
prenatal antiretroviral prophylaxis was significantly associ-
ated with a lower vertical HIV transmission rate
(unadjusted OR 0.23 P < 0.001) [21, 22, 27]. However, in
Sub-Saharan Africa maternal access to ARVs remains sub-
optimal [2]. In our study, vertical transmission rate was
3.6 times higher among the 320 (14.8%) infants whose
mothers did not access prenatal prophylactic ARVs com-
pared to infants whose mothers used prophylactic ARVs.
Type of PMTCT antiretroviral regimen
Currently, the WHO recommended Option B plus –
triple ART is preferred as the most cost effective regi-
men at stemming vertical HIV transmission [3, 5]. Kenya
recently adopted the WHO recommendations during
the last quarter of 2014, and there is already a significant
increase in the proportion of the mothers initiated on
ART as compared to option A. Our findings are consist-
ent with evolution of recommendations on maternal
antiretroviral regime use both nationally and inter-
nationally. With dwindling use of single dose Nevirapine
(1.7%), our findings reflect positive adoption of PMTCT
guidelines and best practices over the years.
Table 4 Determinants of the positivity of HIV exposed infant’s HIV test
Variable name OR [95% CI] p value OR [95% CI] p value
Infant age at diagnosis n = 2624
i. ≤ 6 weeks 1 (Ref) 1 (Ref)
ii. >6 weeks – 9 Months 1.48 [1.09–2.01] 0.012** 1.54 [1.03–2.31] 0.037**
iii. >9 Months 4.60 [3.15–6.73] <0.001** 3.61 [1.80–7.23] <0.001**
Infants’ sex
Female 1 (Ref)
Male 1.22 [0.93–1.60] 0.152* 1.16 [0.84–1.59] 0.368*
Maternal prophylaxis n = 2244
Any form of antiretroviral prophylaxis 1 (Ref) 1(Ref)
No antiretroviral prophylaxis 4.4 [3.2–6.0] <0.001** 2.9 [2.0–4.1] <0.001**
Maternal antiretroviral regimen (type) n = 2244
i. None (did not receive ARVs) 1 (Ref) 1(Ref)
ii. HAART 0.20 [0.14–0.29] <0.001** 0.30 [0.19–0.47] <0.001**
iii. Interrupted HAART 0.15 [0.06–0.35] <0.001** 0.27 [0.11–0.67] 0.003**
iv. AZT + (3TC + sd-NVP at labour) + (AZT + 3TC for 7 days) 0.23 [0.15–0.34] <0.001** 0.41 [0.26–0.65] <0.001**
v. SdNVP 0.06 [0.01–0.47] 0.007** 1
vi. Others 0.37 [0.24–0.58] <0.001** 0.49 [0.29–0.82] 0.005**
Mode of infant feeding
Infants≤ 6 months n=
Exclusive replacement feeding 1 (Ref) 1 (Ref)
Exclusive breastfeeding 1.28 [0.69–2.38] 0.4* 1.27 [0.68–2.38] 0.456*
Mixed feeding 2.75 [1.32–5.70] 0.007** 1.73[0.81–3.7] 0.158*
Infants >6 months
Not breastfed 1 (Ref)
Breast fed 2.3 [1.3–4.0] 0.006** 1.87 [1.02–3.44] 0.043**
Ref reference category, OR Odds ratio, aOR Adjusted Odds ratio
* = Not significant (p > 0.05), ** = Significant (p <0.05), [95% CI] : 95% Confidence interval
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On further analysis, when we adjusted for feeding
option and infant’s age at diagnosis, the odds of vertical
transmission among women on HAART was 79% lower
that of single-dose Nevirapine (aOR 0.21 P < 0.001).
We found no significant difference in transmission
rates between ART and use of AZT plus peripartum
sdNVP -option A (p = 0.211). Our findings are consist-
ent with those of the Kesho Bora trial that compared
extended maternal triple antiretroviral prophylaxis
through 6 months of breastfeeding with prenatal AZT/
sd-NVP without a postpartum component and found
no significant difference [28]. Although data continue
to show equal efficacy between Option A and option B,
use of life-long triple antiretroviral therapy provides
additional benefits of a slowed HIV maternal progres-
sion and averting sexual transmission to sero-
discordant couples [3, 5].
Methodological considerations
Our study has limitations related to missing data, as is
common when using routine service statistics. Further-
more, the unavailability of data on maternal viral load
and peripartum factors made it impossible for our study
to account for the role of these variables on vertical
transmission of HIV. However, an ad hoc analysis of
missing data revealed no significant difference in charac-
teristics. In the end, we restricted our analysis to records
with no missing data. We note that most infants (67.3%)
were reportedly to have been exclusively breastfed.
Whilst this is a desired practice, this high proportion
could be attributed to social desirability bias. Since this
was a self-report, most women would report as expected
by health care providers’ i.e. exclusive breastfeeding for
HIV exposed infants. Our results may not be generalizable
beyond the South Rift region owing to the purposeful
selection of the facilities. Only APHIAPlus-supported
facilities were considered in this study. Despite these limi-
tations, findings from this study are still useful to policy
makers and program managers for continued improve-
ment in the EID program.
Conclusion
PMTCT interventions supported by the APHIAPlus Rift
project were moderately effective in reducing MTCT as
the target of reaching transmission rates of <5% was not
achieved. Early infant age at PCR testing, exclusive breast-
feeding for infants less than 6 months of age, and lifelong
use of maternal ART for prophylaxis are associated with
lowered vertical transmission of HIV. It is possible to
reach the target of MTCT rates of < 5% in Kenya provided
more be done to close the gap for those women and
infants attending the PMTCT sites yet do not access
PMTCT interventions and increase the proportion of
those receiving the more efficacious antiretroviral
prophylaxis regimen. To this end, additional quality im-
provement and health systems strengthening interven-
tions are recommended.
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